Shanghai OPM Biosciences Co. Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai OPM Biosciences Co. Ltd.

Why is Shanghai OPM Biosciences Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 6.53% and Operating profit at -43.06% over the last 5 years

The company has declared positive results in Mar'2025 after 7 consecutive negative quarters

OPERATING CASH FLOW(Y) Highest at CNY 114.81 MM
NET SALES(HY) At CNY 187.85 MM has Grown at 37.97%
NET PROFIT(HY) Higher at CNY 34.51 MM

With ROE of 1.54%, it has a fair valuation with a 3.55 Price to Book Value

Over the past year, while the stock has generated a return of 6.37%, its profits have fallen by -19.8%

Underperformed the market in the last 1 year

The stock has generated a return of 6.37% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shanghai OPM Biosciences Co. Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shanghai OPM Biosciences Co. Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Shanghai OPM Biosciences Co. Ltd.

-4.39%

0.47

53.09%

China Shanghai Composite

16.78%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

19.30%

EBIT Growth (5y)

-47.81%

EBIT to Interest (avg)

31.48

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.56

Sales to Capital Employed (avg)

0.14

Tax Ratio

57.18%

Dividend Payout Ratio

117.13%

Pledged Shares

Institutional Holding

ROCE (avg)

7.48%

ROE (avg)

4.90%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

105

Industry P/E

Price to Book Value

1.46

EV to EBIT

391.05

EV to EBITDA

42.48

EV to Capital Employed

2.31

EV to Sales

4.92

PEG Ratio

1.41

Dividend Yield

ROCE (Latest)

0.59%

ROE (Latest)

1.39%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company

NET PROFIT(9M)

At CNY 18.43 MM has Grown at 58.08%

ROCE(HY)

Highest at 2.73%

NET SALES(Q)

Highest at CNY 182.16 MM

EPS(Q)

Highest at CNY 0.3

-20What is not working for the Company

NET PROFIT(HY)

At CNY 5.65 MM has Grown at -34.39%

RAW MATERIAL COST(Y)

Grown by 20.2% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.11 times

INTEREST(Q)

Highest at CNY 1.78 MM

Here's what is working for Shanghai OPM Biosciences Co. Ltd.

Net Sales

At CNY 182.16 MM has Grown at 105.3%

over average net sales of the previous four periods of CNY 88.73 MM

MOJO Watch

Near term sales trend is extremely positive

Net Sales (CNY MM)

Net Sales

Highest at CNY 182.16 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

EPS

Highest at CNY 0.3

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Here's what is not working for Shanghai OPM Biosciences Co. Ltd.

Net Profit

At CNY 5.65 MM has Grown at -34.39%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 1.78 MM has Grown at 185.86%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest

Highest at CNY 1.78 MM

in the last five periods and Increased by 185.86% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 2.11 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 20.2% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales